Serum of sickle cell disease patients contains fetal hemoglobin silencing factors secreted from leukocytes

References

• PaulingLItanoHASingerSJWellsICSickle cell anemia a molecular diseaseScience1949110286554354815395398
   PubMed Web of Science ®Google Scholar
• CharacheSBartonFBMooreRDHydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive “switching” agent. The Multicenter Study of Hydroxyurea in Sickle Cell AnemiaMedicine (Baltimore)19967563003268982148
   PubMed Web of Science ®Google Scholar
• KaulDKHebbelRPHypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal miceJ Clin Invest2000106341142010930444
   PubMed Web of Science ®Google Scholar
• ReiterCDWangXTanus-SantosJECell-free hemoglobin limits nitric oxide bioavailability in sickle-cell diseaseNat Med200181213831389
   Web of Science ®Google Scholar
• MillerBASalamehMAhmedMHigh fetal hemoglobin production in sickle cell anemia in the eastern province of Saudi Arabia is genetically determinedBlood1986675140414102421808
   PubMed Web of Science ®Google Scholar
• CraigJERochetteJFisherCADissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approachNat Genet199612158648528252
   PubMed Web of Science ®Google Scholar
• CloseJGameLClarkBBergouniouxJGerovassiliATheinSLGenome annotation of a 1.5 Mb region of human chromosome 6q23 encompassing a quantitative trait locus for fetal hemoglobin expression in adultsBMC Genomics200451334615169551
   PubMed Web of Science ®Google Scholar
• YavarianMKarimiMBakkerEHarteveldCLGiordanoPCResponse to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patientsHaematologica200489101172117815477200
   PubMed Web of Science ®Google Scholar
• LettreGSankaranVGBezerraMADNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell diseaseProc Natl Acad Sci U S A200810533118691187418667698
   PubMed Web of Science ®Google Scholar
• BoggsDRHydeFSrodesCAn unusual pattern of neutrophil kinetics in sickle cell anemiaBlood197341159654682080
   PubMed Web of Science ®Google Scholar
• PlattOSBrambillaDJRosseWFMortality in sickle cell disease. Life expectancy and risk factors for early deathN Engl J Med199433023163916447993409
   PubMed Web of Science ®Google Scholar
• MillerSTSleeperLAPegelowCHPrediction of adverse outcomes in children with sickle cell diseaseN Engl J Med20003422838910631276
   PubMed Web of Science ®Google Scholar
• BrawleyOWCorneliusLJEdwardsLRNational Institutes of HealthConsensus Development Conference Statement: hydroxyurea treatment for sickle cell diseaseAnn Intern Med20081481293293818458271
   PubMedGoogle Scholar
• CharacheSDoverGJMooreRDHydroxyurea: effects on hemoglobin F production in patients with sickle cell anemiaBlood19927910255525651375104
   PubMed Web of Science ®Google Scholar
• WareREEgglestonBRedding-LallingerRPredictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapyBlood2002991101411756146
   PubMed Web of Science ®Google Scholar
• ConranNSaadSTCostaFFIkutaTLeukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulating factor in sickle cell diseaseAnn Hematol200786425526117205286
   PubMed Web of Science ®Google Scholar
• IkutaTAdekileADGutsaevaDRThe proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell diseaseBlood Cells Mol Dis201147423524221945571
   PubMed Web of Science ®Google Scholar
• SteinbergMHLuZHBartonFBTerrinMLCharacheSDoverGJFetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of HydroxyureaBlood1997893107810889028341
   PubMed Web of Science ®Google Scholar
• BaileyLKuroyanagiYFranco-PenteadoCFExpression of the gamma-globin gene is sustained by the cAMP-dependent pathway in beta-thalassaemiaBr J Haematol2007138338239517614826
   PubMed Web of Science ®Google Scholar
• KuroyanagiYKanekoYMutaKcAMP differentially regulates gamma-globin gene expression in erythroleukemic cells and primary erythroblasts through c-Myb expressionBiochem Biophys Res Commun200634431038104716631597
   PubMed Web of Science ®Google Scholar
• IkutaTKanYWSwerdlowPSFallerDVPerrineSPAlterations in protein-DNA interactions in the gamma-globin gene promoter in response to butyrate therapyBlood1998928292429339763579
   PubMed Web of Science ®Google Scholar
• SuzukiYTakedaYIkutaTImmunoblotting conditions for human hemoglobin chainsAnal Biochem2008378221822018445469
   PubMed Web of Science ®Google Scholar
• GhoshalPRajendranMOdoNIkutaTGlycosylation inhibitors efficiently inhibit P-selectin-mediated cell adhesion to endothelial cellsPLoS One201496e9936324945938
   PubMed Web of Science ®Google Scholar
• LanzkronSStrouseJJWilsonRSystematic review: hydroxyurea for the treatment of adults with sickle cell diseaseAnn Intern Med20081481293995518458272
   PubMed Web of Science ®Google Scholar
• BorbaRLimaCSGrottoHZReticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapyJ Clin Lab Anal2003172667212640630
   PubMed Web of Science ®Google Scholar
• LeeSPAtagaKIOrringerEPPhillipsDRPariseLVBiologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammationArterioscler Thromb Vasc Biol20062671626163116601237
   PubMed Web of Science ®Google Scholar
• UddinSAh-KangJUlaszekJMahmudDWickremaADifferentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cellsProc Natl Acad Sci U S A2004101114715214694199
   PubMed Web of Science ®Google Scholar
• RodgersGPDoverGJNoguchiCTSchechterANNienhuisAWHematologic responses of patients with sickle cell disease to treatment with hydroxyureaN Engl J Med199032215103710451690857
   PubMed Web of Science ®Google Scholar
• MaQWyszynskiDFFarrellJJFetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyureaPharmacogenomics J20077638639417299377
   PubMed Web of Science ®Google Scholar
• CharacheSDoverGJMoyerMAMooreJWHydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemiaBlood19876911091162431728
   PubMed Web of Science ®Google Scholar
• SteinbergMHManagement of sickle cell diseaseN Engl J Med1999340131021103010099145
   PubMed Web of Science ®Google Scholar
• YarbroJWMechanism of action of hydroxyureaSemin Oncol1992193 Suppl 9110
   PubMed Web of Science ®Google Scholar
• IkutaTAusendaSCappelliniMDMechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathwayProc Natl Acad Sci U S A20019841847185211172039
   PubMed Web of Science ®Google Scholar
• CokicVPSmithRDBeleslin-CokicBBHydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclaseJ Clin Invest2003111223123912531879
   PubMed Web of Science ®Google Scholar
• IkutaTCappelliniMDA novel mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cyclic GMP pathway [abstract]Blood199994615a
   Google Scholar
• PietersRCRojerRASalehAWSalehAEDuitsAJMolgramostim to treat SS-sickle cell leg ulcersLancet19953458948528
   Web of Science ®Google Scholar
• AbboudMLaverJBlauCAGranulocytosis causing sickle-cell crisisLancet19983519107959
   PubMed Web of Science ®Google Scholar
• JiangJJordanSJBarrDPGuntherMRMaedaHMasonRPIn vivo production of nitric oxide in rats after administration of hydroxyureaMol Pharmacol1997526108110869415718
   PubMed Web of Science ®Google Scholar
• GloverREIvyEDOrringerEPMaedaHMasonRPDetection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyureaMol Pharmacol19995561006101010347241
   PubMed Web of Science ®Google Scholar